Antipodean Advisors LLC - Q1 2022 holdings

$138 Million is the total value of Antipodean Advisors LLC's 6 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 33.3% .

 Value Shares↓ Weighting
CVNA  CARVANA COcl a$48,312,000
-48.5%
405,0000.0%34.98%
-9.2%
SE  SEA LTDsponsord ads$41,927,000
-46.5%
350,0000.0%30.36%
-5.6%
CDLX  CARDLYTICS INC$35,121,000
-16.8%
638,8000.0%25.43%
+46.7%
ATRA  ATARA BIOTHERAPEUTICS INC$9,290,000
-41.1%
1,000,0000.0%6.73%
+4.0%
CMAX SellCAREMAX INC$3,175,000
-31.1%
425,000
-29.2%
2.30%
+21.5%
RSX NewVANECK ETF TRUSTvaneck russia et$283,00050,000
+100.0%
0.20%
CLVT ExitCLARIVATE PLC$0-375,000
-100.0%
-3.62%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CARVANA CO21Q2 202338.5%
AMAZON COM INC20Q4 202033.8%
SEA LTD19Q3 202360.8%
CARDLYTICS INC18Q3 202326.3%
MEDICINES CO18Q4 201919.8%
ATARA BIOTHERAPEUTICS INC15Q3 202317.9%
CONSTELLATION BRANDS INC14Q4 201611.1%
HERBALIFE NUTRITION LTD13Q1 202124.8%
CLARIVATE PLC11Q4 202124.4%
EXACT SCIENCES CORP11Q2 201924.6%

View Antipodean Advisors LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Antipodean Advisors LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Oncothyreon Inc.Sold outJanuary 09, 201300.0%

View Antipodean Advisors LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15
13F-HR2021-08-16

View Antipodean Advisors LLC's complete filings history.

Compare quarters

Export Antipodean Advisors LLC's holdings